Veradigm | MDRX - Ebitda


Veradigm reported $38.81M in EBITDA for its fiscal quarter ending in September of 2022.





Ebitda Change Date
Alcidion AUD 4.19M 365K Dec/2025
Ambu A/S DKK 271M 10M Mar/2026
Amplifon EUR 156.24M 14.48M Jun/2026
Cardinal Health USD 1.09B 109M Mar/2026
Centene USD 1.55B 1.01B Jun/2026
Charles River Laboratories USD 229.8M 28.26M Mar/2026
Cigna USD 3.28B 416M Mar/2026
Coloplast 2.39B 132M Sep/2025
Convatec Group USD 286.8M 27.5M Dec/2024
CVS Health USD 5.83B 2.08B Mar/2026
Diasorin EUR 105M 15M Jun/2026
Elevance Health USD 4.21B 2.02B Mar/2026
General Electric Aerospace USD 3.06B 219M Jun/2026
Gulf Medical Proj AED 35.5M 2.9M Mar/2025
Humana USD 2.06B 2.35B Mar/2026
IQVIA Holdings USD 994M 62M Jun/2026
Laboratory Of America USD 767.7M 162.1M Jun/2026
Maximus USD 188.03M 17.61M Mar/2026
McKesson USD 1.88B 206M Dec/2025
Med Life RON 120.37M 12.06M Mar/2026
Molina Healthcare USD 197M 70M Jun/2026
Omnicell USD 67.23M 22.57M Jun/2026
Oriola-kd EUR 7.7M 2.2M Mar/2026
Owens Minor USD 90.02M 2.15M Dec/2025
Quest Diagnostics USD 648M 91M Jun/2026
Rede D'or Sao Luiz BRL 3.59B 505.3M Mar/2026
Siemens Healthineers EUR 1B 104M Mar/2026
Supermax Corporation Bhd MYR -37.85M 103.53M Mar/2026
UnitedHealth USD 9.43B 567M Jun/2026
Veeva Systems USD 403.96M 29.17M Mar/2026
Veradigm USD 38.81M 29.61M Sep/2022
Xerox USD 110M 54M Jun/2025